Senior Preclinical Development Project Lead - DMPK
Bayer
Berlin
Manuela Braun, PhD, Senior DMPK Project Lead/Cell and Gene Therapy (GT) Expert, Bayer AG, Berlin, Germany
Senior scientific expert with 25 years of preclinical and clinical experience in all phases of global drug development with special focus on biologics, RNA modalities, gene and cell therapies. In depth knowledge of DMPK and bioanalysis of various drug classes. Group leader of industry and academia experts working on standardization of pre-existing anti-AAV antibody assays (IMI/ARDAT). Contributing expert to different global gene therapy consortia (IQ Consortium, IMI/ARDAT, EFPIA) focusing on consensus in the development of new modality therapies. Member of the former ICH S12 expert working group.
Disclosure information not submitted.
Hot Topic: Industry Discussions on Companion Diagnostics for AAV-Mediated Gene Therapy
Tuesday, May 6, 2025
10:00 AM - 11:00 AM ET